The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition by Muhammad Saad, Umut Gomceli, Pranav Ravi, Andrisael G Lacoste, Neil Shah, Timothy J Vittorio

Subjects: “…SGLT-2 inhibitors…”
Get full text

Three Levels of Disease Modification with SGLT-2 Inhibitors: Holy Grail in Vasculopathy by Archit Dhaiya; Rajeev Sharma; Nagendra Bhoopathy; Rajeev Agarwal

Subjects: “…Hyperglycemia, SGLT-2, Inhibitors.…”
Get full text

Ketoacidosis without significantly hyperglycaemia - is it possible? by Michał Budzyński, Joanna Pekar, Justyna Magdalena Skolarczyk, Monika Tadla, Katarzyna Skórzyńska-Dziduszko

Subjects: “…SGLT2 inhibitors…”
Get full text

Sodium–glucose cotransporter‐2 inhibitors induced euglycemic diabetic ketoacidosis: Two case reports and a review of the literature by Zouheir Ibrahim Bitar, Ossama Sajeh Maadarani, Fawaz Alabdali, Ahmed Teama, Walid Elsawah, Mohammed Jaber Mohsen, Mahmoud Mostafa Elzoueiry

Subjects: Get full text

An Overview of the Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Hematological Parameters in Diabetic Patients by Ghada Ahmed, Mohammed Abed, Fawaz Alassaf

Subjects: “…sglt2 inhibitors…”
Get full text

SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control by Canan Ersoy

Subjects: “…sglt2 inhibitor…”
Get full text

Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation by Christodoulos Dolapsakis, Emmanouil Karofylakis, Stamatios Chalvatzis

Subjects: “…sglt2 inhibitors…”
Get full text

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis by Hang-Long Li, Gregory-Y. H. Lip, Qi Feng, Yue Fei, Yi-Kei Tse, Mei-zhen Wu, Qing-wen Ren, Hung-Fat Tse, Bernard-M. Y. Cheung, Kai-Hang Yiu

Subjects: “…SGLT2 inhibitors…”
Get full text

Is GFR decline induced by SGLT2 inhibitor of clinical importance? by Merve Günes-Altan, Agnes Bosch, Kristina Striepe, Peter Bramlage, Mario Schiffer, Roland E. Schmieder, Dennis Kannenkeril

Subjects: Get full text

Euglycemic Diabetic Ketoacidosis in a Type 2 Diabetic Patient Treated with Empagliflozin: Case Report by Reza Mohamad Hosein zade Davatgari, Mahsa Soti khiabani, Parviz Shahmirzalou, Maryam Habibi

Subjects: “…sglt2 inhibitors…”
Get full text

Multicenter, open label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP‐STAR study by Hanako Nakajima, Hiroshi Okada, Akinori Kogure, Takafumi Osaka, Takeshi Tsutsumi, Masayoshi Onishi, Kazuteru Mitsuhashi, Noriyuki Kitagawa, Shinichi Mogami, Akane Kitamura, Michiyo Ishii, Naoto Nakamura, Akio Kishi, Sato Eiko, Masahide Hamaguchi, Michiaki Fukui

Subjects: Get full text

Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium‐Glucose Cotransporter‐2 Inhibitors by Jaejin An, John J. Sim, Matt M. Zhou, Hui Zhou, Soon Kyu Choi, Jeffrey W. Brettler, Angeline L. Ong‐Su, Kristi Reynolds

Subjects: Get full text

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives by Chiara Maria Assunta Cefalo, Francesca Cinti, Simona Moffa, Flavia Impronta, Gian Pio Sorice, Teresa Mezza, Alfredo Pontecorvi, Andrea Giaccari

Subjects: “…SGLT2 inhibitors…”
Get full text

The Association of SGLT-2 inhibitors (Empagliflozin) with the development of hypernatremic dehydration: a case report by Diana Alegre-González, Sandra García-Guerreros, Sara Martínez-Hernández, Ana Yasmina Brito-Díaz, Marta Casañas-Martínez, Ramón Baeza-Trinidad

Subjects: “…sglt-2 inhibitors…”
Get full text

Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by... by Kawarasaki S, Sawazaki H, Iijima H, Ng SP, Kwon J, Mohri S, Iwase M, Jheng HF, Takahashi H, Nomura W, Inoue K, Kawada T, Goto T

Subjects: “…sglt2 inhibitor…”
Get full text

SGLT-2 inhibitors in heart failure: a literature review on mechanisms, efficacy and safety by Klaudia Kułak, Katarzyna Chamera-Cyrek, Izabela Janik, Martyna Kuśmierska, Anna Koman, Marzena Pliszka, Katarzyna Gadżała, Karolina Palacz, Izabela Sztybór, Sabina Przygodzka

Subjects: “…SGLT-2 inhibitors…”
Get full text

Clinical Evaluation of Dapagliflozin in the Management of CKD: Focus on Patient Selection and Clinical Perspectives by Nashar K, Khalil P

Subjects: Get full text

Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series by Li MM, Shen WC, Li YJ, Teng J

Subjects: Get full text

Flozins in Reducing Cardiovascular and Metabolic Risk: A Literature Review by Daria Sieniawska, Julia Sieniawska, Patrycja Proszowska

Subjects: “…SGLT2-inhibitors…”
Get full text

Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Transcription Regulation of <i>AgRP</i> and <i>POMC</i> Genes by Dong Hee Kim, Min Jin Lee, Dasol Kang, Ah Reum Khang, Ji Hyun Bae, Joo Yeon Kim, Su Hyun Kim, Yang Ho Kang, Dongwon Yi

Subjects: “…SGLT2 inhibitors…”
Get full text